Abstract
Vaccines have contributed to substantial improvements in health and social development outcomes for millions in recent decades. However, equitable access to immunization remains a critical challenge that has stalled progress toward improving several health indicators around the world. The COVID-19 pandemic has also negatively impacted routine immunization services around the world further threatening universal access to the benefits of lifesaving vaccines. To overcome these challenges, the Immunization Agenda 2030 (IA2030) focuses on increasing both commitment and demand for vaccines. There are three broad barriers that will need to be addressed in order to achieve national and subnational immunization targets: (1) shifting leadership priorities and resource constraints, (2) visibility of disease burden, and (3) social and behavioral drivers. IA2030 proposes a set of interventions to address these barriers. First, efforts to ensure government engagement on immunization financing, regulatory, and legislative frameworks. Next, those in subnational leadership positions and local community members need to be further engaged to ensure local commitment and demand. Governance structures and health agencies must accept responsibility and be held accountable for delivering inclusive, quality, and accessible services and for achieving national targets. Further, the availability of quality immunization services and commitment to adequate financing and resourcing must go hand-in-hand with public health programs to increase access to and demand for vaccination. Last, strengthening trust in immunization systems and improving individual and program resilience can help mitigate the risk of vaccine confidence crises. These interventions together can help ensure a world where everyone, everywhere has access to and uses vaccines for lifesaving vaccination.
Original language | English |
---|---|
Journal | Vaccine |
DOIs | |
Publication status | Accepted/In press - 2022 |
Bibliographical note
Funding Information:This study was made possible partially by the USAID-funded MOMENTUM Country and Global Leadership project, led by Jhpiego. The content of the Article does not necessarily reflect the views of those at the USAID, or the US Government.
Funding Information:
The IA2030 Strategic Priority 2 Commitment and Demand Working Group includes (in alphabetical order): Benjamin Andriamitantsoa, Senad Begić, George Bonsu, John Peter Figueroa, Pradeep Haldar, Gena Hill, Clifford Kamara, Noni MacDonald, Susan Mackay, Lisa Menning, Folake Olayinka, Lora Shimp, Diane Summers, Carmen Tull, and Chizoba Wonodi. The authors greatly appreciate the support provided by Adriana Alminana and Brian Wahl in coordinating the preparation of this manuscript. The authors certify that this article does not include any data that is stored in other platforms. Citations and references used in this article are available per the reference section. This study was made possible partially by the USAID-funded MOMENTUM Country and Global Leadership project, led by Jhpiego. The content of the Article does not necessarily reflect the views of those at the USAID, or the US Government. World Health Organization; JSI Research and Training Institute, Inc
Publisher Copyright:
© 2022
ASJC Scopus Subject Areas
- Molecular Medicine
- General Immunology and Microbiology
- General Veterinary
- Public Health, Environmental and Occupational Health
- Infectious Diseases
PubMed: MeSH publication types
- Journal Article